Skip to main content
. 2023 Dec 11;13:1295228. doi: 10.3389/fonc.2023.1295228

Figure 2.

Figure 2

GDF15 based on diagnosis category. Median GDF15 level [IQR] for bone tumors (N=1, 861pg/mL), brain tumor (N=1, 375.1pg/mL), kidney tumor (N=1, 604.2pg/mL), acute myelogenous leukemia [AML, N=2, 1420.8pg/ml (445.3-2396.3pg/mL)], soft tissue tumor [N= 4, 481.3 pg/mL (411.1-595.2pg/mL)], neuroblastoma [N=5, 774.2pg/mL (763.2-1452.4pg/mL)], lymphoma [N=8, 427.8pg/mL (381.6-624.1pg/mL)], and acute lymphoblastic leukemia [ALL, N=8, 590.6pg/mL (406.7-819.1pg/mL)].